Yet again, the DEA (and FDA) are caught in Bed with a corporation who's interfering and lobbying to protect their bottom line and boost their profits. In 2007, Insys filed a disclosure statement with the Securities and Exchange Commission, directly stating that marijuana legalization would threaten their products. “If marijuana or non-synthetic cannabinoids were legalized in the United States, the market for…